Date: Monday, September 19, 2022
Category: General
RESNA recently submitted public comments to the Centers for Medicare and Medicaid Services (CMS) regarding Medicare Coverage of Seat Elevation Systems as an Accessory to Power Wheelchairs. RESNA has supported the application of power seat elevation, and thus coverage for those who would benefit, since 2010.
It is RESNA’s position that power seat elevation devices are medically necessary. Our position is supported by the evidence reviewed and referenced in the letter to CMS. Evidence indicates that this technology enables certain individuals to:
- Facilitate reach biomechanics, safety and range
- Improve transfer biomechanics, safety and independence
- Enhance visual orientation and line-of-sight
- Support physiological health, safety and well-being
- Decrease hyperlordotic position of the neck
- Promote stable seated positioning
- Reduce symmetric tonic neck reflex (STNR) activity
- Improves safety with performance/participation in ADLs.
- Promote communication, social engagement, self-esteem and integration.
- Improve wheelchair pedestrian safety
The letter was signed by Carmen DiGiovine, President and Rita Stanley, Chair of RESNA’s Government Affairs Committee. Please read the full letter to CMS.
Comments from RESNA members are welcome. Please send any comments directly to Andrea Van Hook, execoffice@resna.org, or to Rita Stanely, at rita.stanley.crt@gmail.com.